<p>Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada</p>-Reference-Cited by-同舟云学术

Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada

Published:2020-04 Issue: Volume:Volume 14 Page:725-735
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Lee Jason K,Amin Suvina,Erdmann Michelle,Kukaswadia Atif^ORCID,Ivanovic Jelena,Fischer Aren,Gendron Alain^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference42 articles.

1. Global Initiative for Asthma. Global strategy for asthma management and prevention; 2018. Available from: https://www.ginasthma.org. Accessed November 16, 2018.

2. Asthma. Statistics Canada; 2015. Available from: https://www150.statcan.gc.ca/n1/pub/82-625-x/2015001/article/14179-eng.htm. Accessed November 16, 2018..

3. Health indicators, annual estimates, 2003–2014. Statistics Canada; 2018. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310045101. Accessed November 26, 2018.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early response to benralizumab in Canadian patients with severe eosinophilic asthma: Interim results from a prospective observational cohort;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2024-04-23

2. Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission;Expert Review of Respiratory Medicine;2023-06-03

3. Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study;Journal of Asthma and Allergy;2023-06

4. Efficacy of two-year anti-IgE therapy in patients with severe allergic bronchial asthma in Sverdlovsk region;Meditsinskiy sovet = Medical Council;2023-04-11

5. Response to Omalizumab as an Add-On Therapy in the Treatment of Allergic Asthma in Adult Chinese Patients—A Retrospective Study;Vaccines;2022-12-02